The International Energy Agency (IEA) stated that Middle East producers’ delay in new oil production investments could lead to higher oil prices due to supply shortages. Although it forecasts the US to become the largest producer of oil worldwide by 2015, the IEA expects US production to decline after 2020. Some Middle Eastern nations have […]
Worldwide expenditures on medicines is forecast to increase 3%–6% between 2013 and 2017 to $1,170–$1,200 billion, excluding off-invoice discounts and rebates. Spending in developed countries is estimated to grow 1%–4% to $650–$680 billion. Spending in pharmerging markets will increase 10%–13% to $370–$400 billion, with spending in China estimated to grow 14%–17% to $160–$190 billion. Spending […]
The Centers for Medicare and Medicaid Services (CMS) finalized pricing for new, analyte-specific molecular codes in late September. Compared to the former stacked code system, which did not list prices for individual tests, the average price of the new codes is 26% higher and the mean price is 25% higher. However, the median price declined […]
The FDA announced this month a proposal to eliminate artificial trans fats that are found in processed foods, such as cookies and frozen pizza. The proposal would classify artificial trans fats as a food additive, and thus requiring regulatory approval. Since 2006, the FDA has required that artificial trans fats be cited on food labels, […]
An October survey of 74 US public and private research universities by the Association of American Universities, the Association of Public and Land-grant Universities (APLU), and the Science Coalition sheds new light on the effects of the US federal budget sequestration, which began in March. Eighty-one percent of respondents reported that the sequestration had an […]
Following the 16-day closure of the US federal government, science agencies are catching up on grant reviews. At the NIH, 200 review panels were canceled, affecting the ranking of 11,000 grant applications. In response to researchers’ pleas, the agency will reschedule the panel meetings for the next two months. The NSF was forced to cancel […]
The US government has averted a helium crisis by passing legislation to continue the operation of the Federal Helium Reserve. Responsible for 30% of the world helium supply, the Reserve will transition from government-set pricing to an auction process. Helium is used to operate MRIs and for semiconductor manufacturing, fiber optics, metallurgy and analytical chemistry. […]
For the one thousand public companies that spend the most on R&D, R&D spending increased 5.8% in fiscal 2013 (the fiscal year ending prior to June 30) to $638 billion, down from 9.6% last year. The total share of revenues spent on R&D increased from 3.43% to 3.60%. Computing and electronics, health care, automotive, industrials, […]
Immunotherapy drugs, known as immune checkpoint inhibitors, could revolutionize cancer treatment and become a major drug market. Bristol-Myers Squibb, Merck & Co. and Roche are among the firms developing such drugs, which use the immune system to target tumor cells. Yervoy, made by Bristol-Myers, the market leader, is approved for treating melanoma, but shows potential […]
Pressure is growing to require accreditation of US food testing labs. The FDA’s Food Safety Modernization Act could require such accreditation, but a proposal addressing the issue has yet to be released. The US has around 25,000 food testing labs, including 5,000 third-party labs, but less than 5% are accredited. Accreditation organizations and some food […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
